EpiGenesis raises $23 million

Pulmonary company EpiGenesis (Princeton, N.J.) raised $23 million in a series A round led by Care Capital. Other investors included Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners; and NJTC Venture Fund. EpiGenesis' EPI-12323 inhaled non-glucocorticoid steroid is in a Phase IIa trial for asthma. ...